Yuki Shibata Selected Research

Glutamic Acid (Glutamate)

1/2018

Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuki Shibata Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 01/2018
3	Inflammation (Inflammations) 01/2023 - 01/2019
2	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2020
2	Contact Dermatitis (Eczema, Contact) 01/2022 - 01/2019
2	AIDS-Related Complex (ARC) 01/2021 - 01/2018
1	Fibrosarcoma 04/2024
1	Liver Diseases (Liver Disease) 03/2024
1	Gastroesophageal Reflux (GERD) 07/2023
1	Hypertrophy 04/2023
1	Pathologic Processes 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Esophageal Motility Disorders (Nutcracker Esophagus) 04/2022
1	Esophageal Achalasia (Megaesophagus) 04/2022
1	Situs Inversus 04/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 07/2021
1	Weight Gain 01/2021
1	Atherosclerosis 01/2021
1	Stress Fractures (Stress Fracture) 10/2020
1	Non-alcoholic Fatty Liver Disease 03/2020
1	Hemangiosarcoma (Angiosarcoma) 12/2019
1	Starvation 01/2019
1	Adenocarcinoma 01/2019
1	Infections 01/2019
1	Melanoma (Melanoma, Malignant) 01/2018
1	Dehydration (Water Stress) 07/2014

Drug/Important Bio-Agent (IBA)

2	ChemokinesIBA 01/2023 - 01/2022
2	erastinIBA 07/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 07/2021 - 01/2018
2	Glutathione (Reduced Glutathione)IBA 01/2019 - 01/2018
1	imidazole ketone erastinIBA 04/2024
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 04/2024
1	Carbon DioxideIBA 07/2023
1	Urea (Carbamide)FDA LinkGeneric 04/2023
1	G(M3) GangliosideIBA 01/2023
1	CytokinesIBA 01/2023
1	HaptensIBA 01/2022
1	eribulin FDA Link 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 07/2021
1	Transferrin (beta 2 Transferrin)IBA 07/2021
1	IronIBA 07/2021
1	GSK-J4IBA 01/2021
1	12-hydroxy-5,8,10,14,17-eicospentaenoic acidIBA 01/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Linseed Oil (Flaxseed Oil)IBA 01/2021
1	LipidsIBA 01/2021
1	HydrogelsIBA 10/2020
1	Thymidine PhosphorylaseIBA 03/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019
1	Radiation-Sensitizing AgentsIBA 01/2019
1	AntioxidantsIBA 01/2019
1	mead acidIBA 01/2019
1	AcidsIBA 01/2019
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2019
1	Coconut OilIBA 01/2019
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	AntiportersIBA 01/2018
1	Cystine (L-Cystine)IBA 01/2018
1	Messenger RNA (mRNA)IBA 07/2014

Therapy/Procedure

4	Therapeutics 03/2024 - 01/2018
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 03/2020
2	Radiotherapy 01/2019 - 01/2018
1	Drug Tapering 03/2024
1	Transplantation 01/2023
1	Myotomy 04/2022